We are interested in understanding the mechanism by which food and pheromone signals are transduced to signal dauer arrest or non-dauer development. Don Riddle's group has identified a TGF-beta homologous pathway that is involved in this signal transduction process.
daf-7 encodes a peptide ligand, and
daf-1 and
daf-4 encode transmembrane serine/threonine kinases that may be receptors for the
daf-7 protein. Recent work by Takao Inoue, Annette Estevez and our laboratory (see abstract by A. Koweek and G. Patterson) has identified a family of genes that are likely to be involved in the signal transduction from these receptors;
daf-8,
daf-14, and
daf-3 are all homologues of the drosophila gene Mad, which transduces signals from serine/threonine kinase receptors. The mechanism by which these receptors and Mad homologues transduce signal is unknown; we are identifying new genes that act in this pathway. In previous screens for suppressors of
daf-7, the genes
daf-3,
daf-5 and
daf-12 were identified by D. Riddle. We have identified four new genes that suppress
daf-7. Two of the genes were identified by mutations that strongly suppress
daf-7; the other two show weak suppression. We are trying to clone a strong suppressor called
scd-1 (Suppressor of Constitutive Dauer formation--pronounced "scud"). We isolated two alleles as suppressors of
daf-7; Takao Inoue provided two alleles he isolated as suppressors or
daf-14 and
daf-8. We mapped the gene between
lin-2 and
unc-9 on X, and we are doing finer mapping as well as injecting candidate cosmids for rescue. We have also begun a screen for suppressors of
daf-3. We are mutagenizing a
daf-7 daf-3 strain (
daf-7 is dauer constitutive,
daf-3 is dauer defective, and the double mutant is dauer defective). We will screen for dauers at 25 degrees C.
daf-2,
daf-19 and
daf-23 are the known dauer constitutive mutants epistatic to
daf-3. We hope to get new mutations that, while not dauer constitutive on their own, suppress the
daf-3 mutation and allow the
daf-7 mutation to force dauer formation. We will screen with both a null
daf-3 allele and a partial loss-of function
daf-3 allele.